EP1523580A2 - Nachweis von mikroorganismen - Google Patents
Nachweis von mikroorganismenInfo
- Publication number
- EP1523580A2 EP1523580A2 EP03765005A EP03765005A EP1523580A2 EP 1523580 A2 EP1523580 A2 EP 1523580A2 EP 03765005 A EP03765005 A EP 03765005A EP 03765005 A EP03765005 A EP 03765005A EP 1523580 A2 EP1523580 A2 EP 1523580A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- oligonucleotides
- oligonucleotide
- microorganisms
- under
- species
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 244000005700 microbiome Species 0.000 title claims abstract description 186
- 238000001514 detection method Methods 0.000 title claims description 47
- 108091034117 Oligonucleotide Proteins 0.000 claims abstract description 331
- 241000894007 species Species 0.000 claims abstract description 83
- 238000000034 method Methods 0.000 claims abstract description 59
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims description 228
- 241000186216 Corynebacterium Species 0.000 claims description 39
- 238000009396 hybridization Methods 0.000 claims description 36
- 230000000295 complement effect Effects 0.000 claims description 33
- 238000011895 specific detection Methods 0.000 claims description 27
- 241000191940 Staphylococcus Species 0.000 claims description 17
- 239000002773 nucleotide Substances 0.000 claims description 17
- 125000003729 nucleotide group Chemical group 0.000 claims description 17
- 241000186427 Cutibacterium acnes Species 0.000 claims description 16
- 241000555676 Malassezia Species 0.000 claims description 16
- 241000191992 Peptostreptococcus Species 0.000 claims description 15
- 241001148134 Veillonella Species 0.000 claims description 13
- 238000005406 washing Methods 0.000 claims description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 11
- 239000003550 marker Substances 0.000 claims description 11
- 230000014670 detection of bacterium Effects 0.000 claims description 10
- 102000004190 Enzymes Human genes 0.000 claims description 9
- 108090000790 Enzymes Proteins 0.000 claims description 9
- 229940088598 enzyme Drugs 0.000 claims description 9
- 238000007901 in situ hybridization Methods 0.000 claims description 9
- 241000204388 Sporomusa Species 0.000 claims description 8
- 230000008823 permeabilization Effects 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 7
- 241000186429 Propionibacterium Species 0.000 claims description 5
- 150000007523 nucleic acids Chemical class 0.000 claims description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 4
- 102000002260 Alkaline Phosphatase Human genes 0.000 claims description 4
- 108020004774 Alkaline Phosphatase Proteins 0.000 claims description 4
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims description 4
- 102000003992 Peroxidases Human genes 0.000 claims description 4
- 210000002421 cell wall Anatomy 0.000 claims description 4
- 230000002255 enzymatic effect Effects 0.000 claims description 4
- 108040007629 peroxidase activity proteins Proteins 0.000 claims description 4
- 239000013641 positive control Substances 0.000 claims description 4
- 238000011002 quantification Methods 0.000 claims description 4
- 229930040373 Paraformaldehyde Natural products 0.000 claims description 3
- 239000003153 chemical reaction reagent Substances 0.000 claims description 3
- 102000039446 nucleic acids Human genes 0.000 claims description 3
- 108020004707 nucleic acids Proteins 0.000 claims description 3
- 229920002866 paraformaldehyde Polymers 0.000 claims description 3
- 108010067770 Endopeptidase K Proteins 0.000 claims description 2
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims description 2
- 108090000988 Lysostaphin Proteins 0.000 claims description 2
- 102000016943 Muramidase Human genes 0.000 claims description 2
- 108010014251 Muramidase Proteins 0.000 claims description 2
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims description 2
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 claims description 2
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 claims description 2
- 108010059712 Pronase Proteins 0.000 claims description 2
- CDXSJGDDABYYJV-UHFFFAOYSA-N acetic acid;ethanol Chemical compound CCO.CC(O)=O CDXSJGDDABYYJV-UHFFFAOYSA-N 0.000 claims description 2
- 230000015556 catabolic process Effects 0.000 claims description 2
- 239000012141 concentrate Substances 0.000 claims description 2
- 239000003431 cross linking reagent Substances 0.000 claims description 2
- 238000006731 degradation reaction Methods 0.000 claims description 2
- 230000010244 detection of fungus Effects 0.000 claims description 2
- 239000004325 lysozyme Substances 0.000 claims description 2
- 229960000274 lysozyme Drugs 0.000 claims description 2
- 235000010335 lysozyme Nutrition 0.000 claims description 2
- 230000002101 lytic effect Effects 0.000 claims description 2
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 claims description 2
- 108010009719 mutanolysin Proteins 0.000 claims description 2
- 239000013642 negative control Substances 0.000 claims description 2
- 230000002285 radioactive effect Effects 0.000 claims description 2
- 239000000523 sample Substances 0.000 description 64
- 210000003491 skin Anatomy 0.000 description 39
- 239000000243 solution Substances 0.000 description 35
- 210000004027 cell Anatomy 0.000 description 23
- 230000008901 benefit Effects 0.000 description 17
- 241000894006 Bacteria Species 0.000 description 16
- 241001517048 Corynebacterium afermentans Species 0.000 description 13
- 241000520076 Corynebacterium coyleae Species 0.000 description 13
- 108020004414 DNA Proteins 0.000 description 11
- 102000053602 DNA Human genes 0.000 description 11
- 235000019688 fish Nutrition 0.000 description 11
- 241000158508 Corynebacterium amycolatum Species 0.000 description 10
- 241000577797 Corynebacterium mucifaciens Species 0.000 description 10
- 241001518260 Corynebacterium minutissimum Species 0.000 description 9
- 239000003599 detergent Substances 0.000 description 9
- 241001517041 Corynebacterium jeikeium Species 0.000 description 8
- 241000024400 Corynebacterium riegelii Species 0.000 description 8
- 241000186245 Corynebacterium xerosis Species 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical group [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 238000003752 polymerase chain reaction Methods 0.000 description 8
- 238000005070 sampling Methods 0.000 description 8
- 241000186248 Corynebacterium callunae Species 0.000 description 7
- 241001533284 Corynebacterium glucuronolyticum Species 0.000 description 7
- 241000186226 Corynebacterium glutamicum Species 0.000 description 7
- 241001495430 Corynebacterium kutscheri Species 0.000 description 7
- 241000334665 Corynebacterium lipophiloflavum Species 0.000 description 7
- 241000186225 Corynebacterium pseudotuberculosis Species 0.000 description 7
- 241000158523 Corynebacterium striatum Species 0.000 description 7
- 229920002477 rna polymer Polymers 0.000 description 7
- 244000005714 skin microbiome Species 0.000 description 7
- 241001517050 Corynebacterium accolens Species 0.000 description 6
- 241000186145 Corynebacterium ammoniagenes Species 0.000 description 6
- 241000334677 Corynebacterium camporealensis Species 0.000 description 6
- 241000186246 Corynebacterium renale Species 0.000 description 6
- 229940055019 propionibacterium acne Drugs 0.000 description 6
- 241000379991 Anaerococcus Species 0.000 description 5
- 241000880909 Corynebacterium durum Species 0.000 description 5
- 241001517043 Corynebacterium genitalium Species 0.000 description 5
- 241000158520 Corynebacterium urealyticum Species 0.000 description 5
- 241000351207 Peptoniphilus Species 0.000 description 5
- 241000191963 Staphylococcus epidermidis Species 0.000 description 5
- 241000191980 Staphylococcus intermedius Species 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 239000002537 cosmetic Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- 108020004465 16S ribosomal RNA Proteins 0.000 description 4
- 208000002874 Acne Vulgaris Diseases 0.000 description 4
- 241001464907 Anaerococcus hydrogenalis Species 0.000 description 4
- 241001518270 Corynebacterium pseudogenitalium Species 0.000 description 4
- 241001464881 Peptoniphilus lacrimalis Species 0.000 description 4
- 206010000496 acne Diseases 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 244000005706 microflora Species 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 229920003023 plastic Polymers 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 241001464884 Anaerococcus lactolyticus Species 0.000 description 3
- 241000530054 Anaerococcus octavius Species 0.000 description 3
- 241001464864 Anaerococcus vaginalis Species 0.000 description 3
- 241001508000 Corynebacterium bovis Species 0.000 description 3
- 241000158496 Corynebacterium matruchotii Species 0.000 description 3
- 241001617393 Finegoldia Species 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241001464887 Parvimonas micra Species 0.000 description 3
- 241001147736 Staphylococcus capitis Species 0.000 description 3
- 241000191965 Staphylococcus carnosus Species 0.000 description 3
- 241001147698 Staphylococcus cohnii Species 0.000 description 3
- 241001220267 Staphylococcus condimenti Species 0.000 description 3
- 241000520126 Staphylococcus delphini Species 0.000 description 3
- 241000201871 Staphylococcus felis Species 0.000 description 3
- 241000191984 Staphylococcus haemolyticus Species 0.000 description 3
- 241000192087 Staphylococcus hominis Species 0.000 description 3
- 241000192101 Staphylococcus muscae Species 0.000 description 3
- 241001220301 Staphylococcus piscifermentans Species 0.000 description 3
- 241000192097 Staphylococcus sciuri Species 0.000 description 3
- 241000191978 Staphylococcus simulans Species 0.000 description 3
- 241001533204 Veillonella dispar Species 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 238000012364 cultivation method Methods 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 238000011835 investigation Methods 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 210000003705 ribosome Anatomy 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- BCHIXGBGRHLSBE-UHFFFAOYSA-N (4-methyl-2-oxochromen-7-yl) dihydrogen phosphate Chemical compound C1=C(OP(O)(O)=O)C=CC2=C1OC(=O)C=C2C BCHIXGBGRHLSBE-UHFFFAOYSA-N 0.000 description 2
- YCCILVSKPBXVIP-UHFFFAOYSA-N 2-(4-hydroxyphenyl)ethanol Chemical compound OCCC1=CC=C(O)C=C1 YCCILVSKPBXVIP-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- JRBJSXQPQWSCCF-UHFFFAOYSA-N 3,3'-Dimethoxybenzidine Chemical compound C1=C(N)C(OC)=CC(C=2C=C(OC)C(N)=CC=2)=C1 JRBJSXQPQWSCCF-UHFFFAOYSA-N 0.000 description 2
- YRNWIFYIFSBPAU-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=C(N(C)C)C=C1 YRNWIFYIFSBPAU-UHFFFAOYSA-N 0.000 description 2
- 241000588624 Acinetobacter calcoaceticus Species 0.000 description 2
- 241001464890 Anaerococcus prevotii Species 0.000 description 2
- 241001464898 Anaerococcus tetradius Species 0.000 description 2
- 241000193401 Clostridium acetobutylicum Species 0.000 description 2
- 241000168411 Corynebacterium auris Species 0.000 description 2
- 241001495432 Corynebacterium cystitidis Species 0.000 description 2
- 241001517042 Corynebacterium fastidiosum Species 0.000 description 2
- 241001134763 Corynebacterium flavescens Species 0.000 description 2
- 241000940098 Corynebacterium freneyi Species 0.000 description 2
- 241001517018 Corynebacterium macginleyi Species 0.000 description 2
- 241001518268 Corynebacterium mycetoides Species 0.000 description 2
- 241001495433 Corynebacterium pilosum Species 0.000 description 2
- 241000159540 Corynebacterium segmentosum Species 0.000 description 2
- 241000895659 Corynebacterium thomssenii Species 0.000 description 2
- 241000918600 Corynebacterium ulcerans Species 0.000 description 2
- 241000186244 Corynebacterium variabile Species 0.000 description 2
- 241001518266 Corynebacterium vitaeruminis Species 0.000 description 2
- 238000000018 DNA microarray Methods 0.000 description 2
- 241000206602 Eukaryota Species 0.000 description 2
- 241000192016 Finegoldia magna Species 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 241000605986 Fusobacterium nucleatum Species 0.000 description 2
- 108010015776 Glucose oxidase Proteins 0.000 description 2
- 239000004366 Glucose oxidase Substances 0.000 description 2
- 241000203280 Halocella cellulosilytica Species 0.000 description 2
- 241000191953 Kocuria varians Species 0.000 description 2
- 241000555688 Malassezia furfur Species 0.000 description 2
- 241001299738 Malassezia pachydermatis Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000192041 Micrococcus Species 0.000 description 2
- 241000191938 Micrococcus luteus Species 0.000 description 2
- 108091061960 Naked DNA Proteins 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 241000530062 Peptoniphilus harei Species 0.000 description 2
- 241000192035 Peptostreptococcus anaerobius Species 0.000 description 2
- 241000835315 Spirosoma pulveris Species 0.000 description 2
- 241001147686 Staphylococcus arlettae Species 0.000 description 2
- 241001147687 Staphylococcus auricularis Species 0.000 description 2
- 241001147695 Staphylococcus caprae Species 0.000 description 2
- 241000201854 Staphylococcus chromogenes Species 0.000 description 2
- 241001033898 Staphylococcus equorum Species 0.000 description 2
- 241000192085 Staphylococcus gallinarum Species 0.000 description 2
- 241001147689 Staphylococcus kloosii Species 0.000 description 2
- 241000147121 Staphylococcus lentus Species 0.000 description 2
- 241001134656 Staphylococcus lugdunensis Species 0.000 description 2
- 241000193817 Staphylococcus pasteuri Species 0.000 description 2
- 241001147691 Staphylococcus saprophyticus Species 0.000 description 2
- 241000861996 Staphylococcus succinus Species 0.000 description 2
- 241000191973 Staphylococcus xylosus Species 0.000 description 2
- 241000193996 Streptococcus pyogenes Species 0.000 description 2
- 241001533207 Veillonella atypica Species 0.000 description 2
- 241001148135 Veillonella parvula Species 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 2
- 108010005774 beta-Galactosidase Proteins 0.000 description 2
- 102000005936 beta-Galactosidase Human genes 0.000 description 2
- 230000027455 binding Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000012928 buffer substance Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 229940116332 glucose oxidase Drugs 0.000 description 2
- 235000019420 glucose oxidase Nutrition 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000003068 molecular probe Substances 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 229940074571 peptostreptococcus anaerobius Drugs 0.000 description 2
- NMHMNPHRMNGLLB-UHFFFAOYSA-N phloretic acid Chemical compound OC(=O)CCC1=CC=C(O)C=C1 NMHMNPHRMNGLLB-UHFFFAOYSA-N 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 230000000644 propagated effect Effects 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
- GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 1
- IHPYMWDTONKSCO-UHFFFAOYSA-N 2,2'-piperazine-1,4-diylbisethanesulfonic acid Chemical compound OS(=O)(=O)CCN1CCN(CCS(O)(=O)=O)CC1 IHPYMWDTONKSCO-UHFFFAOYSA-N 0.000 description 1
- FPNZBYLXNYPRLR-UHFFFAOYSA-N 2-(4-carbamimidoylphenyl)-1h-indole-6-carboximidamide;hydron;dichloride Chemical compound Cl.Cl.C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FPNZBYLXNYPRLR-UHFFFAOYSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- KUWPCJHYPSUOFW-YBXAARCKSA-N 2-nitrophenyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC=C1[N+]([O-])=O KUWPCJHYPSUOFW-YBXAARCKSA-N 0.000 description 1
- KDXNYSZNOWTPLE-UHFFFAOYSA-N 3'-hydroxy-6'-methoxyspiro[2-benzofuran-3,9'-xanthene]-1-one Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(OC)=CC=C21 KDXNYSZNOWTPLE-UHFFFAOYSA-N 0.000 description 1
- AZKSAVLVSZKNRD-UHFFFAOYSA-M 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide Chemical compound [Br-].S1C(C)=C(C)N=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=CC=C1 AZKSAVLVSZKNRD-UHFFFAOYSA-M 0.000 description 1
- PCDWFBFHIIKIPM-UHFFFAOYSA-N 3-ethyl-2h-1,3-benzothiazole-2-sulfonic acid Chemical compound C1=CC=C2N(CC)C(S(O)(=O)=O)SC2=C1 PCDWFBFHIIKIPM-UHFFFAOYSA-N 0.000 description 1
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
- YUDPTGPSBJVHCN-DZQJYWQESA-N 4-methylumbelliferyl beta-D-galactoside Chemical compound C1=CC=2C(C)=CC(=O)OC=2C=C1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O YUDPTGPSBJVHCN-DZQJYWQESA-N 0.000 description 1
- BZTDTCNHAFUJOG-UHFFFAOYSA-N 6-carboxyfluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C11OC(=O)C2=CC=C(C(=O)O)C=C21 BZTDTCNHAFUJOG-UHFFFAOYSA-N 0.000 description 1
- 102000013563 Acid Phosphatase Human genes 0.000 description 1
- 108010051457 Acid Phosphatase Proteins 0.000 description 1
- 241000604451 Acidaminococcus Species 0.000 description 1
- 241000604450 Acidaminococcus fermentans Species 0.000 description 1
- 241001621846 Anaeromusa acidaminophila Species 0.000 description 1
- 241001135699 Arcanobacterium Species 0.000 description 1
- 241000193838 Atopobium parvulum Species 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 241000193755 Bacillus cereus Species 0.000 description 1
- 241000193422 Bacillus lentus Species 0.000 description 1
- 241000194106 Bacillus mycoides Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 208000035985 Body Odor Diseases 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 241000193403 Clostridium Species 0.000 description 1
- 241001531199 Clostridium moniliforme Species 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 241000427397 Corynebacterium aurimucosum Species 0.000 description 1
- 241000422843 Corynebacterium auriscanis Species 0.000 description 1
- 241000323759 Corynebacterium casei Species 0.000 description 1
- 241001644925 Corynebacterium efficiens Species 0.000 description 1
- 241000024402 Corynebacterium imitans Species 0.000 description 1
- 241001313296 Corynebacterium simulans Species 0.000 description 1
- 241000334945 Corynebacterium sundsvallense Species 0.000 description 1
- 241001464974 Cutibacterium avidum Species 0.000 description 1
- 241001464975 Cutibacterium granulosum Species 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 1
- 241000408655 Dispar Species 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241001491901 Filobasidium magnum Species 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
- 241000351213 Gallicola Species 0.000 description 1
- 241001509412 Gordonia sputi Species 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 241000186655 Halobacillus halophilus Species 0.000 description 1
- 241000122047 Helcococcus kunzii Species 0.000 description 1
- 241001247263 Helcococcus ovis Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 208000034693 Laceration Diseases 0.000 description 1
- 241000973043 Macrococcus caseolyticus Species 0.000 description 1
- 241000187722 Micromonospora echinospora Species 0.000 description 1
- NNINRCJBMXIZSU-UHFFFAOYSA-N N.N.C1=CC(N)=CC=C1C1=CC=C(N)C=C1 Chemical compound N.N.C1=CC(N)=CC=C1C1=CC=C(N)C=C1 NNINRCJBMXIZSU-UHFFFAOYSA-N 0.000 description 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
- 208000025157 Oral disease Diseases 0.000 description 1
- 239000007990 PIPES buffer Substances 0.000 description 1
- 241000194105 Paenibacillus polymyxa Species 0.000 description 1
- 241000589779 Pelomonas saccharophila Species 0.000 description 1
- 241001464921 Phascolarctobacterium Species 0.000 description 1
- 241001464924 Phascolarctobacterium faecium Species 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 241000186428 Propionibacterium freudenreichii Species 0.000 description 1
- 241000186340 Propioniferax innocua Species 0.000 description 1
- 241000588767 Proteus vulgaris Species 0.000 description 1
- 241000589776 Pseudomonas putida Species 0.000 description 1
- 241000186336 Pseudopropionibacterium propionicum Species 0.000 description 1
- 102000002278 Ribosomal Proteins Human genes 0.000 description 1
- 108010000605 Ribosomal Proteins Proteins 0.000 description 1
- 241000187810 Saccharomonospora viridis Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 206010040904 Skin odour abnormal Diseases 0.000 description 1
- 241000204384 Sporomusa paucivorans Species 0.000 description 1
- 241000295644 Staphylococcaceae Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000191982 Staphylococcus hyicus Species 0.000 description 1
- 241001464905 Staphylococcus saccharolyticus Species 0.000 description 1
- 241001234013 Staphylococcus vitulinus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000124841 Succiniclasticum ruminis Species 0.000 description 1
- 241001310961 Succinispira mobilis Species 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 241000186064 Trueperella pyogenes Species 0.000 description 1
- DZGWFCGJZKJUFP-UHFFFAOYSA-N Tyramine Natural products NCCC1=CC=C(O)C=C1 DZGWFCGJZKJUFP-UHFFFAOYSA-N 0.000 description 1
- 241001478284 Variovorax paradoxus Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010048222 Xerosis Diseases 0.000 description 1
- 241001531183 [Eubacterium] yurii Species 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000002313 adhesive film Substances 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229940044726 anaerococcus tetradius Drugs 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- PRQROPMIIGLWRP-BZSNNMDCSA-N chemotactic peptide Chemical compound CSCC[C@H](NC=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 PRQROPMIIGLWRP-BZSNNMDCSA-N 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 230000037310 combination skin Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000036758 dandruff formation Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 229960000633 dextran sulfate Drugs 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 1
- SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 1
- VIYFPAMJCJLZKD-UHFFFAOYSA-L disodium;(4-nitrophenyl) phosphate Chemical compound [Na+].[Na+].[O-][N+](=O)C1=CC=C(OP([O-])([O-])=O)C=C1 VIYFPAMJCJLZKD-UHFFFAOYSA-L 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000834 fixative Substances 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 239000008098 formaldehyde solution Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000013160 medical therapy Methods 0.000 description 1
- KBOPZPXVLCULAV-UHFFFAOYSA-N mesalamine Chemical compound NC1=CC=C(O)C(C(O)=O)=C1 KBOPZPXVLCULAV-UHFFFAOYSA-N 0.000 description 1
- 229960004963 mesalazine Drugs 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 239000013580 millipore water Substances 0.000 description 1
- 208000030194 mouth disease Diseases 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000000282 nail Anatomy 0.000 description 1
- 239000006225 natural substrate Substances 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 239000002853 nucleic acid probe Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- -1 p-Ucresol (*) Chemical compound 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 201000001245 periodontitis Diseases 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 229940007042 proteus vulgaris Drugs 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000012113 quantitative test Methods 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- JGVWCANSWKRBCS-UHFFFAOYSA-N tetramethylrhodamine thiocyanate Chemical compound [Cl-].C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=C(SC#N)C=C1C(O)=O JGVWCANSWKRBCS-UHFFFAOYSA-N 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 229960003732 tyramine Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
Definitions
- the invention relates to a kit for the detection of microorganisms containing at least one oligonucleotide for at least one species or a group of species of microorganisms which are present on the skin, and also to a method in which the kit according to the invention is used.
- the human skin for example, with an area of approximately 2 m 2, is one of the largest human body organs inhabited by microorganisms. In the course of evolution, a close relationship has developed between the host and its microbial inhabitants. The nutrients made available by the skin through various body glands are metabolized by microorganisms. The resulting acidification of the skin surface prevents the settlement of pathogenic microorganisms.
- the metabolic activity of microorganisms can also have undesirable consequences.
- the development of body odor, dandruff formation and the development of various skin diseases can be attributed to the activity of microbes.
- Resident flora microorganisms that can multiply on human skin or are found regularly when examining skin samples in large numbers or with a high proportion. It is postulated that the above-mentioned properties come about through the firm anchoring of these resident microorganisms with the skin (attachment).
- Transient flora microorganisms that cannot multiply on the human skin or are found only irregularly and in small numbers / proportions during examinations. According to the theory, these microorganisms are free and do not adhere to skin components.
- microorganisms The detection of microorganisms is still predominantly carried out serologically or microscopically.
- the methods are not sensitive enough to directly detect small amounts of microorganisms. For this reason, a cultivation step in which the microorganisms were propagated has been carried out up to now.
- a disadvantage of this method is that some of the microorganisms do not grow on the available nutrient media and therefore cannot be detected.
- Studies on various environmental samples show that e.g. Currently only between 0.1 to 14% of all bacteria can be cultivated. Cultivation-dependent methods have proven to be unsuitable, in particular for analyzing the composition of a complex biocenosis.
- hybridization means in particular the formation of a double helix from two single-stranded, complementary oligo- or polynucleotides. Hybridization can in particular arise between two DNA or two RNA molecules, but also between DNA and RNA molecules. The different molecules hybridize only if the target sequences are sufficiently complementary to one another.
- the complementary target sequences for the detection can also be immobilized, as is often done on so-called DNA chips.
- a carrier DNA chip
- Oligonucleotides which are complementary to known reference sequences of certain bacteria or viruses which occur in the oral flora are immobilized on this support. Due to the complementarity, the oligonucleotides applied to this gene chip can hybridize with the corresponding reference sequences under certain conditions.
- a disadvantage of this carrier is that the microorganisms either have to be propagated by cultivation or the genetic information from the samples present has to be amplified on the chip before hybridization.
- PCR polymerase chain reaction
- PCR DNA-amplifying enzyme
- Taq polymerase a DNA-amplifying enzyme
- a further development of the PCR technique is quantitative PCR, in which an attempt is made to establish a correlation between the amount of microorganisms present and the amount of amplified DNA.
- the advantages of PCR are its high specificity and the short time it takes.
- Significant disadvantages are their high susceptibility to contamination and the false positive results they cause, as well as the aforementioned lack of ability to differentiate between living and dead cells or naked DNA, and finally the risk of false negative results due to the presence of inhibitory substances.
- FISH fluorescence in situ hybridization
- microorganism species, species or groups can be identified in the sample in a highly specific manner and, if necessary, visualized or quantified. This method is the only method that provides a distortion-free representation of the actual in situ conditions of the biocenosis. Even microorganisms that have not yet been cultivated and therefore not described can be identified.
- probes penetrate the cells in the sample under investigation. If a microorganism of the type, genus or group for which the probes were developed is present in the sample under investigation, the probes in the microorganism cell bind to their target sequence and the cells can be detected on the basis of the labeling of the probes.
- probes can be used to detect numerous microorganisms that traditional cultivation does not detect. While only a maximum of 15% of the bacterial population of a sample can be made visible by cultivation, the FISH technique allows detection of up to 100% of the total bacterial population in many samples. Second, the detection of microorganisms using the FISH technique is much faster than using cultivation. If the identification of microorganisms by cultivation often takes several days, it only takes a few hours from sampling to microorganism identification even at the species level using the FISH technique. Thirdly, in contrast to a cultivation medium, the specificity of probes can be chosen almost arbitrarily. Individual species can be detected with a probe just as easily as entire genera or groups of microorganisms.
- microorganism types or entire microorganism populations can be precisely quantified directly in the sample.
- associations and associations of different microorganisms can be visualized in one sample.
- the FISH reliably detects only living microorganisms. False positive results due to bare DNA or dead microorganisms such as PCR are excluded with the FISH. Furthermore, false negative results due to the presence of inhibitory substances are excluded, as are false positive results due to contamination.
- the FISH technique is therefore an outstanding tool for quickly and extremely specifically detecting microorganisms directly in a sample. In contrast to cultivation methods, it is a direct method and also allows the microorganisms contained in the sample to be quantified.
- the object of the present invention is therefore to enable the detection of microorganisms or groups of such microorganisms, which come into contact with humans in particular, in such a way that a rapid and possibly quantitative determination of these microorganisms in a sample is ensured and, moreover, individual ones or groups of species of microorganisms can be reliably detected even in the presence of other microorganisms.
- kits for the detection of microorganisms containing at least one oligonucleotide for at least one species or a group of species of microorganisms which are present on the skin, and by the provision of a method in which the kit according to the invention is used.
- skin is understood to mean human and / or animal skin or mucous membrane and the appendages of the skin (hair, hair follicles, nails, glands).
- microorganism group is to be understood as meaning at least two types of microorganisms which either belong to the same genus or are very similar have rRNA.
- a microorganism group according to the invention can also contain, for example, all species of a genus.
- microorganism groups e.g. B. to search for their occurrence or other parameters.
- a number or all species of a genus e.g. of the genus Corynebacterium, which occur on the skin, are to be understood as a group of species selected from this genus, in this case Corynebacterium.
- the kit or set according to the invention can contain both an oligonucleotide for a specific species, a plurality of oligonucleotides for a species, one or more oligonucleotides for a group of species of microorganisms and a plurality of oligonucleotides for two or more groups of microorganisms.
- oligonucleotides or a combination of these in the kit according to the invention for the detection of all microorganisms of a genus.
- This has the advantage that it is also possible to detect those species of a certain genus which have hitherto not been able to be cultivated or have been difficult to cultivate or which have hitherto not been detected in such samples.
- specific oligonucleotides for the genus Malassezia all types of this fungus can be detected in one sample.
- the oligonucleotides contained in the kit according to the invention can also be selected specifically for only a single species (type) of the microorganisms mentioned. In this way, it is advantageously possible to detect microorganism species that have special properties, the appearance of which on the skin is discussed, for example, in connection with diseases. You can use such special probes alongside other species of the same genus as well as sequence-like microorganisms can be detected. This is e.g. B. interesting when examining acne, because the Propionibacterium acnes with a P. acnes-specific oligonucleotide can be detected precisely and specifically in samples that also contain other Propionibacteria.
- the kit or set according to the invention contains at least one or more oligonucleotides, for example in a solution (e.g. a buffer solution) or a mixture (e.g. in the lyophilized state).
- a solution e.g. a buffer solution
- a mixture e.g. in the lyophilized state
- the oligonucleotides can also be present next to each other separately (e.g. in different vessels).
- the oligonucleotide can be complementary to a chromosomal or episomal DNA, but also to an mRNA or rRNA of the microorganism to be detected. It is advantageous to choose an oligonucleotide which is complementary to a region which is present in the number of copies of more than 1 in the microorganism to be detected.
- the sequence to be detected is preferably 500-100,000 times per cell, particularly preferably 1,000-50,000 times.
- the rRNA is preferably used as the target site, since the ribosomes in the cell as sites of protein biosynthesis are present thousands of times in each active cell.
- the oligonucleotide in the sense of the invention can be a DNA or RNA oligonucleotide which will generally comprise between 12 and 1000 nucleotides, preferably between 12 and 100, particularly preferably between 12 and 50, in particular between 16 and 25 nucleotides.
- the oligonucleotides are selected on the basis of whether a suitable complementary sequence is present in the microorganism to be detected.
- a sequence is suitable if, on the one hand, it is specific for the microorganism to be detected and, on the other hand, it is accessible at all to the penetrating oligonucleotide, that is, it is not masked by ribosomal proteins or rRNA secondary structures.
- a type of microorganism, a type of microorganism or a group of microorganisms can be recorded. Complementarity should exist for an oligonucleotide of 15 nucleotides over 100% of the sequence. For oligonucleotides with more than 15 nucleotides, one or more mismatching sites are allowed.
- kit according to the invention can contain oligonucleotides for the detection of the resident microflora of the skin.
- Another advantage is the possibility to quantify the detected microorganisms. For the first time, insights into the absolute and relative quantitative relationships of the microorganisms mentioned in the skin microflora can be obtained. This enables the success and all effects of this treatment to be checked before, during and after medical or cosmetic treatment. In this context, it is also advantageous that the method according to the invention only detects living microorganisms.
- the microorganisms are selected from the genera Staphylococcus, Peptostreptococcus,
- the microflora of the skin has so far only been investigated using the known cultivation methods. Due to the methodological deficiency already mentioned, only cultivable bacteria or fungi were detected. Examples of such species are: Staphylococcus aureus, S. epidermidis, S. cohnii, S. haemolyticus, S. hominis, S. capitis, S. warn, S. sciuri, S. schleifen, S. intermedius, Veillonella spec, Propionibacterium acnes , Malassezia sloffiae, M. pachydermatis, M. furfur, Corynebacterium minutissimum, C. amycolatum, C. striatum and C. xerosis.
- kits according to the invention which in particular the oligonucleotides with the same or similar sequence according to SEQ ID NO. 19 to 30 possible to detect certain species of a genus in addition to other microorganism species, even if they belong to the same genus.
- the detection of the microorganisms is carried out by means of in-situ hybridization, in particular with the aid of the fluorescence in-situ hybridization method.
- a quantification of different microorganism populations possible with FISH technology is also advantageous.
- Conclusions regarding the interaction of populations of different microorganisms can then be drawn from the cell numbers determined and z. B. for therapy or other measures.
- a kit with several oligonucleotides for different species or groups of species can be used advantageously.
- the kit according to the invention contains at least one oligonucleotide for the species Propionibacterium acnes.
- the kit according to the invention can also contain at least one oligonucleotide for other groups or species of microorganisms.
- the kit or set according to the invention contains at least one oligonucleotide for the species Propionibacterium acnes and at least one oligonucleotide for a species or group of species of Staphylococcus.
- the kit according to the invention contains at least one oligonucleotide for at least one species or group of species from Malassezia.
- the yeast Malassezia is suspected to be particularly involved in the scaling of the skin, for example on the head.
- the kit according to the invention can convey new knowledge in this regard by examining test subjects with and without dandruff with the kit and the Results are compared. Clinical samples can also be tested for Malassezia using the kit according to the invention.
- the oligonucleotide carries a detectable marker (preferably a fluorescent marker), which is in particular covalently bound to the oligonucleotide.
- a detectable marker preferably a fluorescent marker
- the detectability of the hybridization of the oligonucleotide with the target sequence is a prerequisite for the identification and, if necessary, quantification of the microorganisms. In particular, this is often achieved by covalently binding a detectable marker to the oligonucleotide.
- Fluorescent groups e.g.
- Cy-2, Cy-3 or Cy-5 (Amersham Life Sciences, Inc., Arlington Heights, USA), FITC (fluorescein isothiocyanate), CT (5, (6) - carboxytetramethylrhodamine-N-hydroxysuccinimide ester (Molecular Probes Inc., Eugene , USA)), TRITC (tetramethylrhodamine-5,6-isothiocyanate (Molecular Probes Inc., see above) or FLUOS (5, (6) -carboxyfluorescein-N-hydroxysuccinimide ester (Boehringer Mannheim, Mannheim, Germany)).
- chemiluminescent groups or radioactive labels for example 35S, 32P, 33P, 125 J.
- detectability can also be provided by coupling the oligonucleotide to an enzymatically active molecule, for example alkaline phosphatase, acid phosphatase, peroxidase, horseradish peroxidase, ⁇ -D-galactosidase or glucose oxidase.
- an enzymatically active molecule for example alkaline phosphatase, acid phosphatase, peroxidase, horseradish peroxidase, ⁇ -D-galactosidase or glucose oxidase.
- chromogens are known for each of these enzymes, which can be converted instead of the natural substrate and can be converted into either colored or fluorescent products he chromogens are given in Table 1 below.
- Peroxidase tyramine hydrochloride (*), 3- (p-hydroxyphenyl) propionic acid (*), p-hydroxyphenethyl alcohol (*), 2,2'-azino-bis (3-ethylbenzothiazoline sulfonic acid) (ABTS), ortho-phenylenediamine dihydrochloride, o-Dianisidine, 5-aminosalicylic acid, p-Ucresol (*), 3,3'-dimethyloxybenzidine, 3-methyl-2-benzothiazolinehydrazone, tetramethylbenzidine
- oligonucleotides so that at their 5 ' or 3' end there is another nucleic acid sequence suitable for hybridization.
- This nucleic acid sequence in turn comprises approximately 15 to 1,000, preferably 15 to 50 nucleotides.
- This second nucleic acid region can in turn be recognized by an oligonucleotide which can be detected by one of the means mentioned above.
- Another possibility is to couple the detectable oligonucleotides to a hapten, which is then to the hapten recognizing antibody can be brought into contact.
- Digoxigenin can be cited as an example of such a hapten. The skilled worker is also well known about the examples given.
- the enzymatic marker is selected from a group consisting of peroxidase, preferably horseradish peroxidase, and phosphatase, preferably alkaline phosphatase.
- the kit contains at least one oligonucleotide selected from the group consisting of: i) oligonucleotides with those in SEQ ID NO. 01 to 30 specified
- oligonucleotides which differ from one of those mentioned under i) and ii)
- oligonucleotides the sequence being deleted or extended by one or more nucleotides, and iv) oligonucleotides, which have a sequence which belongs to one of the
- Oligonucleotides under i), ii) or iii) is complementary, under stringent
- oligonucleotides with the in SEQ ID NO. 01 to 18 specified sequences as well as those oligonucleotides that match these at least in 80%, preferably in at least 84%, particularly preferably in at least 90%, very particularly preferably in 95% of the nucleotides, also includes those oligonucleotides that differ from the named ones Derive oligonucleotides, wherein they are extended or deleted by one or more nucleotides.
- oligonucleotides which correspond to these at least in 77%, preferably in at least 83%, particularly preferably in at least 88%, very particularly preferably in 94% of the nucleotides, also includes those oligonucleotides which differ from the named ones Derive oligonucleotides, wherein they are extended or deleted by one or more nucleotides.
- 1 to 40 preferably 1 to 25, in particular 1 to 15 nucleotides to be appended to the 3 'and / or 5' end of the oligonucleotides mentioned.
- oligonucleotides which can be derived from the oligonucleotides mentioned in particular by deleting the sequence by 1 to 7, preferably 1 to 5, in particular one to three, for example one or two, nucleotides.
- a particular advantage is the high specificity of the selected oligonucleotides. Specifically determined genera or groups of microorganisms can be detected as well as highly specific individual species of a genus.
- the kit or set according to the invention can be used for the quick and efficient detection of microorganisms which occur on the skin, in particular by means of the FISH method. It is also possible to use the oligonucleotide sequences as probes in other processes, e.g. immobilized on a gene chip.
- the kit according to the invention i) contains at least one oligonucleotide for the specific detection of bacteria of the genus Staphylococcus selected from the group consisting of a) oligonucleotides with the in SEQ ID NO. 01 to 03 specified
- oligonucleotides which correspond to the oligonucleotides under a) in accordance with the statements of claim 10 ii) and c) oligonucleotides which match the oligonucleotides in a) according to the statements in claim 10 iii) and d) oligonucleotides which correspond with a Hybridize sequence which is complementary to one of the oligonucleotides under a), b) or c) under stringent conditions.
- Genus Peptostreptococcus selected from the group consisting of a) oligonucleotides with the in SEQ ID NO. 04 to 06 and 27 to 29 sequences indicated, and b) oligonucleotides which correspond to the oligonucleotides under a) according to the details of claim 10 ii) and c) oligonucleotides which match the oligonucleotides under a) according to the details of claim 10 iii ) agree and d) oligonucleotides which hybridize with a sequence which is complementary to one of the oligonucleotides under a), b) or c) under stringent conditions.
- oligonucleotide for the specific detection of bacteria of the genus Corynebacterium selected from the group consisting of a) oligonucleotides with the in SEQ ID NO. 07 to 12 and 19 to 26 specified sequences, and b) oligonucleotides which correspond to the oligonucleotides under a) in accordance with the details of claim 10 ii) and c) oligonucleotides which match the oligonucleotides in a) in accordance with the details in claim 10 iii) and d) oligonucleotides which have a sequence which is complementary to one of the oligonucleotides under a), b) or c) hybridize under stringent conditions.
- oligonucleotide for the specific detection of bacteria of the genus Veillonella selected from the group consisting of a) oligonucleotides with the in SEQ ID NO. 13 to 15 specified sequences, and b) oligonucleotides which correspond to the oligonucleotides under a) according to the details of claim 10 ii) and c) oligonucleotides which correspond to the oligonucleotides under a) according to the details of claim 10 iii) and d ) Oligonucleotides which hybridize with a sequence which is complementary to one of the oligonucleotides under a), b) or c) under stringent conditions.
- oligonucleotide for the specific detection of bacteria of the species Propionibacterium acnes selected from the group consisting of a) oligonucleotides with the in SEQ ID NO. 16 and 17 specified
- oligonucleotides which correspond to the oligonucleotides under a) in accordance with the details of claim 10 ii) and c) oligonucleotides which match the oligonucleotides in a) in accordance with the details in claim 10 iii) and d) oligonucleotides which have a sequence which is complementary to one of the oligonucleotides under a), b) or c) hybridize under stringent conditions.
- Genus Malassezia selected from the group consisting of a) an oligonucleotide with the in SEQ ID NO. 18 specified sequence and b) oligonucleotides which correspond to the oligonucleotide under a) according to the details of claim 10 ii) and c) oligonucleotides which correspond to the oligonucleotide under a) according to the details of claim 10 iii) and d) oligonucleotides, which hybridize with a sequence which is complementary to one of the oligonucleotides under a), b) or c) under stringent conditions
- oligonucleotide for the specific detection of microorganisms from the sporomusa taxon selected from the group consisting of a) an oligonucleotide with the in SEQ ID NO.
- oligonucleotides which correspond to the oligonucleotide under a) according to the details of claim 10 ii) and c) oligonucleotides which match the oligonucleotide under a) in accordance with the statements of claim 10 iii) and d) oligonucleotides which are stringent with a sequence which is complementary to one of the oligonucleotides under a), b) or c) Hybridize conditions.
- the kit according to the invention in particular enables the specific detection of microorganisms of the genera Staphylococcus, Peptostreptococcus, Propionibacterium, Corynebacterium, Veillonella, Malassezia and / or the Sporomusa taxon.
- kits according to the invention For example, the selection of one or more oligonucleotides each from one of groups i), ii), iii), iv), v), vi) or vii) to be understood by it.
- oligonucleotides selected from four groups ie from group i) with ii), iii) and iv) are also to be used; i) with ii), iii) and v); i) with ii), iii) and vi), i) with ii), iii) and vii); i) with ii), iv) and v); i) with ii), iv) and vi); i) with ii), iv) and vi); i) with ii), v) and vi), i) with ii), v) and vii); i) with ii), vi) and vii); i) with iii), vi) and vii); i) with iii), vi) and vii); i) with iii), vi) and vii); i) with iii), vi) and vii); i) with iii), vi) and vii
- the kit according to the invention is therefore suitable for detecting a microorganism species or a group of microorganisms.
- one or more oligonucleotides according to i) are selected, for example, for the detection of certain species of Staphylococcus.
- the detection of species and / or groups of microorganisms of the different genera mentioned can be carried out simultaneously and / or side by side.
- the detection of microorganisms of the genus Staphylococcus (by selecting one or more oligonucleotides according to i)) can be carried out simultaneously and / or next to one another to detect microorganisms of the genus Corynebacterium (by selecting one or more oligonucleotides according to iii) ) occur.
- the kit can be individually adapted to the respective requirements.
- kits contain oligonucleotides for the specific detection of microorganisms of the genus Staphylococcus, the oligonucleotides being complementary to the rRNA and being selected from a group consisting of oligonucleotides with those under SEQ ID NO. 01 to 03 specified sequences.
- Each of the specified oligonucleotides detects at least one of the following species of the genus Staphylococcus: S. aureus, S. epidermidis, S. saccharolyticus, S. caprae, S. capitis, S. warn, S. pasteuri, S. arlettae, S. gallinarum, S. cohnii, S. succinus, S. kloosii, S. saprophyticus, S. equorum, S. xylosus, S. haemolyticus, S. hominis, S. lugdunensis, S. chromogenes, S. auricularis, S. schleifen, S. sciuri, S.
- microorganisms with a similar rRNA sequence are not covered by these oligonucleotides: Paenibacillus polymyxa, Bacillus lentus, Bacillus cereus, Bacillus subtilis, Bacillus mycoides, Proteus vulgaris, Burkholderiausocococides, and Bokholderia cepacis.
- Paenibacillus polymyxa Bacillus lentus
- Bacillus cereus Bacillus subtilis
- Bacillus mycoides Proteus vulgaris
- Burkholderiausocococides Burkholderiausocococides
- Bokholderia cepacis Bokholderia cepacis
- the oligonucleotide according to SEQ ID NO. 02 is for the detection of microorganisms of the genus Staphylococcus, in particular of S. intermedius, S. delphini, S. muscae, S. condimenti, S. piscifermentans, S. carnosus, S. schleifen, S. felis and S. simulans, preferred by S. intermedius and S. schleifen.
- the combination of the oligonucleotides in the kit according to the invention with those under SEQ ID NO is particularly preferred. 01 to 02 specified sequences.
- This combination detects at least the following species of the genus Staphylococcus: S. aureus, S. epidermidis, S. caprae, S. capitis, S. warn, S. pasteuri, S. arlettae, S. gallinarum, S. cohnii, S. succinus , S. kloosii, S. saprophyticus, S. equorum, S. xylosus, S. haemolyticus, S. hominis, S. lugdunensis, S. chromogenes, S.
- kits contain oligonucleotides for the specific detection of microorganisms of the genus Peptostreptococcus, the oligonucleotides being complementary to the rRNA and being selected from a group consisting of oligonucleotides with those under SEQ ID NO. 04 to 06 and 27 to 29 specified sequences.
- the bacteria known under the generic name "Peptostreptococcus” can be assigned to various subgroups, in particular the genera Anaerococcus, Peptoniphilus or Finegoldia, according to the latest findings.
- Each of the specified oligonucleotides detects at least one of the following species of the genera Anaerococcus, Peptoniphilus or Finegoldia belonging to the generic term "Peptostreptococcus”: P. assaccharolyticus, P. lacrimalis, P. hareii, F. magnus, A. tetradius, A. hydrogenalis, A. lactolyticus, A. octavius, and A. vagina lis.
- oligonucleotides with the under SEQ ID NO. 04 to 06 specified sequences. These oligonucleotides each detect at least the following peptostreptococcal species, in particular those of the genus Anaerococcus: Anaerococcus hydrogenalis, A. lactolyticus, A. octavius, A. prevotii, Anaerococcus tetradius and A. vaginalis.
- the species of the genus Peptostreptococcus mentioned below and other microorganisms with a similar rRNA sequence, but which do not belong to the genus Peptostreptococcus, in particular Anaerococcus, are not covered: Peptoniphilus lacrimalis, Peptostreptococcus anaerobius, Finegoldia magniotus, and Ruminididoccus product, and Ruminidocibus product, as well as Ruminidococcus Clostridium hastiform.
- This oligonucleotide detects at least the following species of the microorganisms falling under the generic term "Peptostreptococcus”: Anaerococcus hydrogenalis, A. lactolyticus, A. octavius, A. prevotii and A. vaginalis.
- the kit according to the invention also contains oligonucleotides for the specific detection of microorganisms of the genus Peptostreptococcus, the oligonucleotides being complementary to the rRNA and being selected from a group consisting of oligonucleotides with the sequence shown in SEQ ID NO.
- the species of the genus Peptostreptococcus mentioned below and other microorganisms with a similar rRNA sequence, but which do not belong to the peptostreptococci, are not recorded; Micromonas micros, Helcococcus kunzii, Helcococcus ovis.
- oligonucleotides detect at least the following species of the genus Peptoniphilus: Peptoniphilus assaccharolyticus, P. hareii, P. indoHeus (in particular the ATCC 29427 strain and those strains which are closely related to it, ie have a very similar rRNA) and P. lacrimalis.
- Pseudomonas saccharophila Variovorax paradoxus
- Finegoldia magna Staphylococcus epidermidis
- Propionibacterium acnes Micromonas micros, Gallicola baranese, Atopobium parvulum, Veilonella dispar and Cseudiesococcus putida, as well as Pseudomonocacterium putida and Pseudomonocacterium putida.
- the oligonucleotide with the under SEQ ID No. 28 specified sequence detects in particular microorganisms of the species Peptoniphilus lacrimalis.
- the oligonucleotide with that under SEQ ID NO. 29 specified sequence.
- This oligonucleotide detects at least the species Finegoldia magna from the microorganisms falling under the generic term "peptostreptococci" and those microorganisms which are very similar in their rRNA sequence, while the following microorganisms cannot be detected at the same time: Anaerococcus hydrogenalis, Peptostreptococcus anaerhilus, Pepton lacrimalis, Staphylococcus epidermidis, Halocella cellulosilytica, Propionibacterium acnes, Micromonas micros, Veillonella dispar, Pseudomonas putida and other species of the genera Anaerococcus, Corynebacterium and Peptoniphilus.
- kits contain oligonucleotides for the specific detection of microorganisms of the genus Corynebacterium, the oligonucleotides being complementary to the rRNA and being selected from a group consisting of oligonucleotides with those under SEQ ID NO. 07 to 12 specified sequences.
- Each of the specified oligonucleotides detects at least one of the following species of the genus Corynebacterium: C. glutamicum, C. lipophiloflavum, C. glucuronolyticum, C. macginleyi, C. accolens, C. fastidiosum, C. segmentosum, C. ammoniagenes, C. minutissimum, C. flavescens, C. coyleiae, C. afermentans, C. pseudogenitalium, C. genitalium, C. mucofaciens, C. auris, C. mycetoides, C. cystitidis, C. pilosum, C. pseudotuberculosis, C.
- ulcerans C. diphteriae, C. vitarumen, C. kutscheri, C. genitalium, C. argentoratens, C. callunae, C. bovis, C. variabilis, C. amycolatum, C. "tuberculostearicum", C. xerosis, C. matruchotii, C. jeikeium, C. efficiens, C. thomsenii, C. nigricans, C. auriscanis, C. mooreparkense, C. casei, C. camporealensis, C. sundsvallense, C. mastidis, C. imitans, C. riegelii, C. asperum, C. freneyi, C. striatum, C. coyleiae and C. simulans.
- the oligonucleotide with the one under SEQ ID NO. 10 specified sequence used for the detection of Corynebacteria of the species C. striatum and / or C. xerosis.
- oligonucleotide with the under SEQ ID NO. 11 specified sequence used for the detection of Corynebacteria of the species C. jeikeium.
- the combination of the oligonucleotides detects at least the following species of the genus Corynebacterium: C. glutamicum, C. lipophiloflavum, C. glucuronolyticum, C. macginleyi, C. accolens, C. fastidiosum, C. segmentosum, C. ammoniagenes, C. minutissimum, C. flavescens , C. coyleiae, C. afermentans, C. pseudogenitalium, C. "genitalium”, C. mucofaciens, C. auris, C.
- the kit according to the invention furthermore contains oligonucleotides for the specific detection of microorganisms of the genus Corynebacterium, the oligonucleotides being complementary to the rRNA and being selected from a group consisting of oligonucleotides with those under SEQ ID NO. 19 to 26 specified sequences.
- Each of the specified oligonucleotides detects at least one of the following species of the genus Corynebacterium: C. coyleiae, C. afermentans, C. "genitalium”, C. mucifaciens, C. amycolatum, C. “tuberculostearicum” and C. riegelii. These oligonucleotides are suitable for specifically detecting a group from one or more, very closely related species of the genus Corynebacterium.
- microorganisms with a similar rRNA sequence are advantageously not detected by these oligonucleotides: Clostridium acetobutylicum, Eubacterium yurii and Fusobacterium nucleatum.
- the following bacteria belonging to the skin microflora are also not recorded: Micrococcus luteus, Micrococcus varians, Micrococcus lyae, Acinetobacter calcoaceticus and Streptococcus pyogenes. This is a particular advantage and shows the high specificity of the probes.
- the oligonucleotide with the one under SEQ ID NO. 19 specified sequence for the detection of a group of microorganisms from the genus Corynebacterium used by C. "tuberculostearicum" (in particular ATCC 35692) or the group around the strain with the designation CDC G5840 (Acc. No. X80498) and such microorganisms is formed, which have a very similar rRNA.
- microorganisms which are very closely related to the microorganism or whose rRNA has a high degree of identity and / or in particular in the section hybridizing with the oligonucleotide mentioned with the rRNA of the said microorganisms completely or almost completely (ie with a deviation of one or more, preferably one to three nucleotides) agree.
- This probe advantageously detects C. "tuberculostearicum” and the species of the genus Corynebacterium that have a very similar rRNA without detecting the following, more closely related species of the genus Corynebacterium: C. minutissimum, C. diphteriae, C. striatum, C. xerosis, C. "fastidiosum", C. camporealensis, C. accolens and C. "pseudogenitalium” as well as C. afermentans, C. jeikeium, C. durum, C. mucifaciens, C. renale, C. riegelii, C. glutamicum, C. lipophiloflavum, C. glucuronolyticum C. ammoniagenes, C. coyleiae, C. pseudotuberculosis, C. kutscheri, C. callunae and C. urealyticum.
- C. amycolatum and species closely related to this species is the probe with the probe under SEQ ID NO. 20 specified sequence used.
- This probe advantageously detects C. amycolatum, and those species of the genus Corynebacterium which have a very similar rRNA and which, in particular in the portion of the rRNA hybridizing with said oligonucleotide, has only a few, preferably no mismatches, without the following, more distant related species of the To detect genus Corynebacterium; C. "asperum", C. jeikeium, C. bovis, C. freneyi, C. afermentans, C. durum, C. matruchotii, C.
- mucifaciens C. renale, C. glutamicum, and C. xerosis and C. lipophiloflavum , C. glucuronolyticum, C. minutissimum, C. ammoniagenes, C. camporealensis, C. coyleiae, C. pseudotuberculosis, C. riegelii, C. kutscheri, C. callunae and C. urealyticum.
- the oligonucleotide with the one under SEQ ID NO. 21 specified sequence for the detection of certain species of microorganisms, in particular the genus Corynebacterium, which with the partial sequence of 16 S rRNA indicated under Seq ID No 31 is used in at least 60%, preferably in at least 70%, particularly preferably in at least 80% and entirely particularly preferably in at least 90%, for example at least 95% of the nucleotides match.
- This probe advantageously detects the specified species of the genus Corynebacterium without detecting the following, more closely related species of the genus Corynebacterium: C. "genitalium", C. mucifaciens, C. coyleiae, C. glucuronolyticum, C.
- the oligonucleotide with the one under SEQ ID NO. 23 specified sequence used for the detection of Corynebacteria of the species C. afermentans.
- This probe advantageously detects C. afermentans and those species of the genus Corynebacterium which have a rRNA very similar to these species without detecting the following, more distant, related species of the genus Corynebacterium: C. "genitalium", C. mucifaciens, C. ammoniagenes, C. coyleiae, C. glucuronolyticum, C. riegelii, C. thomssenii. C. pseudogenitalium and C. lipophiloflavum as well as C. amycolatum, C. jeikeium, C. durum, C. renale, C. striatum, C. glutamicum, C. accolens, C.
- the oligonucleotide with the one under SEQ ID NO. 25 specified sequence used for the detection of Corynebacteria of the species C. afermentans, C. mucifaciens, C. coyleiae and / or "C. genitalium"
- This probe advantageously detects C. afermentans, C. mucifaciens, C. coyleiae and "C. genitalium” as well as those species of the genus Corynebacterium which have an rRNA very similar to these species without detecting the following, more closely related species of the genus Corynebacterium: C xerosis, C. jeikeium, C. urealyticum, C. amycolatum, C. glutamicum, C. striatum, C. accolens, C. renale, C. ammoniagenes and C. kutscheri as well as C. glucuronolyticum, C. camporealensis, C. pseudotuberculosis, C. durum, C. minutissimum, C. lipophiloflavum, C. callunae and C. thomssenii.
- This oligonucleotide also does not detect the following microorganisms, which do not belong to the genus Corynebacterium, but have a similar rRNA: Nanomurea fastidiosa, Micromonospora echinospora, Abiotropha elegans and Arcanobacterium pyogenes.
- kits contain oligonucleotides for the specific detection of microorganisms of the genus Veillonella, the probes being complementary to the rRNA and being selected from a group consisting of oligonucleotides with those under SEQ ID NO. 13 to 15 specified sequences.
- Each of the specified oligonucleotides detects at least one of the following species of the genus Veillonella: V. dispar, V. parvula and V. atypica. Since the genus Veillonella is largely isolated in the phylogenetic family tree, advantageously no detection of non-target organisms is found.
- a combination of the oligonucleotides with those under SEQ ID NO. Is particularly preferred in the kit according to the invention. Contain 13 to 14 specified sequences. This combination detects at least the following species of the genus Veillonella: V. dispar, V. parvula and V. atypica.
- the kit according to the invention contains oligonucleotides for the specific detection of microorganisms of the species Propionibacterium acnes, the probes being complementary to the rRNA and being selected from a group consisting of oligonucleotides with those under SEQ ID NO. 16 to 17 specified sequences.
- Each of the specified oligonucleotides specifically detects the Propionibacterium acnes species.
- a kit which contains the oligonucleotide with the sequence shown under SEQ ID NO. 16 specified sequence contains.
- microorganisms with a similar rRNA sequence are not recorded: P. propionicus, P. granulosum, P. avidum, P. freudenreichii, P. thoeni, P. lymphophilus, C. minutissimum, Saccharomonospora viridis, Nocardiodes spec, Propioniferax innocua, Gordonia sputi and Arcanobacterium.
- kits contain oligonucleotides for the specific detection of microorganisms of the genus Malassezia, the oligonucleotide being complementary to the rRNA and those under SEQ ID NO. Has 18 specified sequence.
- the specified oligonucleotide detects at least one of the following species of the genus Malassezia: M. sloffiae, M. pachydermatis, M. furfur.
- the specified oligonucleotide detects at least the species Acidaminococcus fermentans, Phascolarctobacterium faecium and with them closely related microorganisms with very similar rRNA, but not the following microorganisms: Veillonella spec. Halobacillus halophilus, Sporomusa paucivorans, Macrococcus caseolyticus, Anaeromusa acidaminophila, Halocella cellulosilytica, Peptostreptococcus anaerobius, Succiniclasticum ruminis and Succinispira mobilis.
- a kit according to the invention can contain not only labeled oligonucleotides but also unlabeled oligonucleotides and can be used in the detection of microorganisms.
- the incubation of samples with unlabelled and labeled oligonucleotides preferably serves to increase the specificity of the probes. For example, it is possible to distinguish closely related species from microorganisms by using an oligonucleotide for an undetectable species that is closely related to a species to be detected, which under the selected conditions hybridizes better with the target sequence of the rRNA of the undetectable microorganism than that marked probe.
- the unlabeled probe hybridizes better with the rRNA of the undetectable microorganism than the labeled probe, binding of the labeled probe to the rRNA of the undetectable microorganism and thus a false positive result is prevented by using the unlabeled oligonucleotide (competitor).
- the specific detection of certain microorganism species or groups of microorganisms is thereby made possible, especially in the presence of closely related species with a very similar rRNA sequence.
- the oligonucleotide according to SEQ ID No. 21 it is suitable according to the invention, together with the oligonucleotide according to SEQ ID No. 21 the oligonucleotide according to SEQ ID No. 22 to use.
- the oligonucleotide according to SEQ ID No. 21 marked and the oligonucleotide according to SEQ ID No. 22 used unmarked.
- the microorganism species, the 16 S rRNA sequence of which is shown under SEQ ID No. 31 specified sequence includes, can be detected easily, without that C. afermentans is detected at the same time (compare analysis result in the example). It can also be suitable according to the invention to use oligonucleotides of SEQ ID No. Use 23 and 24 together.
- oligonucleotide with SEQ ID No. 23 marked as a probe is used to detect C. afermentans, masks the oligonucleotide according to SEQ ID No. 24 the very similar target sequence of the microorganism species, the 16 S rRNA sequence of which is shown under SEQ ID No. 31 specified sequence includes.
- oligonucleotide according to SEQ ID No. 26 as an unlabeled competitor together with the oligonucleotide according to SEQ ID No. 25 are used.
- the kit additionally contains at least one oligonucleotide for the detection of other microorganism species, groups or genera.
- kits in addition to one or more oligonucleotides according to SEQ ID No. 19 to 30 contains one or more further oligonucleotides for the detection of species of the genera Staphylococcus, Veillonella, Malassezia and / or Propionibacterium. Different skin-relevant microorganisms can then advantageously be detected simultaneously or in parallel in a sample, in particular in a single process or method.
- oligonucleotides disclosed herein are particularly suitable, in particular those according to SEQ ID NO. 1 to 18.
- a kit is particularly suitable, for example, which, in addition to one, more or all oligonucleotides, has a sequence according to SEQ ID NO. 19 to 30 contains one or more oligonucleotides which can detect a larger group of the microorganisms to be detected. For example, it can make sense to first identify those samples with one or more probes that contain microorganisms of the genus Corynebacterium, and then to examine the positive samples specifically for individual microorganism species or groups within the genus Corynebacterium.
- Preferred oligonucleotides which can in particular also be used in combination for the detection of many different species of the genus Corynebacterium, preferably for the detection of skin-relevant species of the genus Corynebacterium, are the oligonucleotides with a sequence according to SEQ ID NO. 7 to 12, in particular according to SEQ ID No. 7, 8, 10 and 11, in particular when using the oligonucleotides according to SEQ ID NO. 7, 8, 10 and 11.
- one or more of the above-mentioned oligonucleotides according to SEQ ID No. 19 to 26 can be added to the kit.
- This kit can contain (in particular when used in an in-situ hybridization method the important hybridization solutions with the respective oligonucleotides for the microorganisms to be detected as important components. Furthermore, it can also contain a corresponding hybridization solution without oligonucleotides and the corresponding washing solution or a Concentrate of the corresponding washing solution, which may also contain enzyme solutions, fixation solutions and, if appropriate, an embedding solution for carrying out a positive control and a negative control in parallel (for example without or with non-hybridizing oligonucleotides).
- the implementation of the method according to the invention comprises the following steps: a) taking a sample from the skin b) fixing the microorganisms contained in the sample taken c) incubating the fixed microorganisms with at least one oligonucleotide in order to bring about hybridization d) removing non-hybridized oligonucleotides and e) Detecting and possibly quantifying the microorganisms hybridized with the oligonucleotides.
- fixing the microorganisms is understood to mean a treatment with which the microorganism shell is made permeable to oligonucleotides. Ethanol is usually used for fixation. If the cell wall cannot be penetrated by the oligonucleotides using these measures, the person skilled in the art is sufficiently aware of further measures which lead to the same result. These include, for example, methanol, mixtures of alcohols, a low-percentage paraformaldehyde solution or a dilute formaldehyde solution or the like.
- the fixed cells are incubated with, in particular, fluorescence-labeled oligonucleotides for the “hybridization”. After penetration of the cell envelope, these may bind to the target sequence corresponding to the oligonucleotide.
- the bond is to be understood as the formation of hydrogen bonds between complementary pieces of nucleic acid.
- oligonucleotides of the kit according to the invention are used in the context of the method according to the invention with a suitable hybridization solution.
- suitable compositions of this solution are well known to those skilled in the art.
- Such a hybridization solution contains, for example, formamide in a concentration between 0% and 80%, from 0 - 45%, particularly preferably from 20% to 40% and has, for example, a salt concentration (the salt is preferably NaCl) between 0.1 mol / l and 1, 5 mol / l, preferably between 0.5 and 1.0 mol / l, particularly preferably 0.9 mol / l.
- a detergent usually SDS
- a suitable buffer substance eg Tris-HCl, Na citrate, HEPES, PIPES or the like
- the pH of the hybridization solution is generally between 6.0 and 9.0, preferably between 7.0 and 8.0, particularly preferably around 8.0.
- additives can be used, e.g. fragmented salmon sperm DNA or blocking reagents to prevent nonspecific binding in the hybridization reaction or polyethylene glycol, polyvinylpyrrolidone or dextran sulfate to accelerate the hybridization reaction.
- substances can also be added which stain the DNA of all living and / or organisms contained in the sample (e.g. DAPI, 4 ', 6-diamidino-2-phenylindole dihydrochloride).
- DAPI fragmented salmon sperm DNA
- 4 ', 6-diamidino-2-phenylindole dihydrochloride e.g. DAPI, 4 ', 6-diamidino-2-phenylindole dihydrochloride.
- the concentration of the oligonucleotide in the hybridization solution depends on the type of its labeling and the number of target structures. In order to enable fast and efficient hybridization, the number of oligonucleotides should exceed the number of target structures by several orders of magnitude. However, it should be borne in mind that an excessive amount of fluorescence-labeled oligonucleotides leads to increased background fluorescence.
- the concentration of the oligonucleotides should therefore be in a range between 0.5 - 500 ng / ⁇ l.
- the preferred concentration in the context of the method according to the invention is 1-10 ng of each oligonucleotide used per ⁇ l hybridization solution.
- the volume of the hybridization solution used should be between 8 ⁇ l and 100 ml, in a preferred embodiment of the method according to the invention it is between 10 ⁇ l and 1000 ⁇ l, particularly preferably it is between 20 ⁇ l and 40 ⁇ l.
- the duration of the hybridization is usually between 10 minutes and 12 hours; hybridization is preferably carried out for about 1.5 hours.
- the hybridization temperature is preferably between 44 ° C and 48 ° C, particularly preferably 46 ° C, the parameter of the hybridization temperature, as well as the concentration of salts and detergents in the hybridization solution, depending on the oligonucleotides, in particular their lengths and the degree of complementarity can be optimized to the target sequence in the cell to be detected.
- the person skilled in the art is familiar with the relevant calculations here.
- this washing solution can contain 0.001-0.1% of a detergent such as SDS, with a concentration of 0.01% being preferred, as well as Tris-HCl or another suitable buffer substance in a concentration of 0.001-0.1 mol / l , preferably 0.02 mol / I, the pH being in the range from 6.0 to 9.0, preferably around 8.0.
- the detergent may be included but is not essential.
- the washing solution usually also contains NaCl, the concentration depending on the stringency required being from 0.003 mol / l to 0.9 mol / l, preferably from 0.01 mol / l to 0.9 mol / l.
- a NaCl concentration of 0.07 mol / l is particularly preferred.
- NaCl concentrations of 0.05-0.22 mol / l are particularly suitable.
- the washing solution can also contain EDTA, the concentration preferably being 0.005 mol / l.
- the washing solution can also contain preservatives known to the person skilled in the art in suitable amounts.
- the "washing off" of the unbound oligonucleotides is usually carried out at a temperature in the range from 44 ° C. to 52 ° C., preferably from 44 ° C. to 50 ° C. and particularly preferably at 44 ° C. to 48 ° C. for a period of 10- 40 minutes, preferably 15 minutes.
- the final evaluation is possible with a light microscope, epifluorescence microscope, chemiluminometer, fluorometer, etc.
- the speed of this detection method is a particular advantage. While traditional cultivation takes up to seven days for detection, the result is available within three hours after using the method according to the invention. This enables for the first time an accompanying diagnostic control of the effects and undesirable effects of an applied treatment. It is also advantageous here that the method provided according to the invention makes it possible to detect all of the microorganisms mentioned at the same time, which means a further time advantage, since all steps from sampling to evaluation need only be carried out once.
- Another major advantage is that it is now possible for the first time to simultaneously detect these medically and cosmetically relevant microorganisms of the skin microflora.
- By using different markers for the oligonucleotides all, several or individual groups or species of microorganisms can be detected in parallel and clearly differentiated from one another, as required. It also allows the population relationships of these microorganism groups or species and the interactions between them to be analyzed for the first time. For the first time, this opens up the possibility of a clear diagnosis and targeted treatment of medically and / or cosmetically relevant skin problems. It is now possible for the first time to have the effects of medical therapy or cosmetic Treatment to capture the total microflora of the skin. Possible effects as well as undesirable effects of a treatment can be recognized early and can be strengthened or prevented in the further treatment.
- kit according to the invention can now be used for the first time in this method to detect those microorganisms of the skin microflora which have not previously been recorded by the traditional detection methods.
- oligonucleotide or the oligonucleotides used a wide variety of groups of microorganisms can be detected. On the one hand, it is possible to detect large groups of microorganisms, but also smaller subgroups that are closely related, and even individual species specifically, in addition to other, also closely related species of microorganisms.
- the sample is obtained from the skin surface in step a) of the method.
- a detergent solution which is intended to facilitate the detachment of the microorganisms from the skin surface.
- Physiologically acceptable detergents such as. B. Tween or Triton, used in concentrations of about 0.01-1 wt .-%.
- the skin surface is rubbed off with the help of a scraping instrument.
- rods of different thicknesses e.g. B. with a diameter of 0.05 to 1.5 cm, made of different materials such as glass, metal or plastic.
- Spatulas made of the materials mentioned with a rounded surface are also suitable.
- Glass rods between 0.4 and 0.8 cm in diameter or plastic spatulas are preferred.
- Plastic spatulas with a rough surface are particularly suitable, for example a sampling spatula made of glass fiber reinforced polyamide from Merck (Art. No. 231J2412, double spatula, length 180 mm). Also suitable according to the invention are rubbing with swabs and the sampling by clapping with more viscous media or skin tears with adhesive films (for example commercial household adhesive strips). In these methods, the microorganisms can be obtained from these objects, for example, by washing with an appropriate buffer solution. The further procedure can also be carried out directly on the adhesive strip.
- fixation is carried out by i) denaturing reagents, preferably selected from a group consisting of ethanol, acetone and ethanol-acetic acid mixtures, ii) crosslinking reagents, preferably selected from a group consisting of formaldehyde, paraformaldehyde and glutaraldehyde, or iii) as heat fixation
- the microorganisms can be immobilized on a support after being fixed.
- the fixed cells of the microorganisms are permeabilized before step c) of the method according to the invention.
- permeabilization means an enzymatic treatment of the cells. This treatment makes the cell wall of fungi and gram-positive bacteria permeable to the oligonucleotides. Enzymes suitable for this, their suitable concentrations and solvents suitable for these are known to the person skilled in the art. It goes without saying that the method according to the invention is also suitable for analyzing gram-negative bacteria; the enzymatic treatment for permeabilization is then adapted accordingly, and this can then be dispensed with entirely.
- Permeabilization of the cells prior to hybridization has the advantage that the oligonucleotides can penetrate the cells, but the ribosomes and thus the rRNA cannot escape from the cells.
- the great advantage of this technique of whole cell hybridization is that the morphology of the bacteria remains intact and that these intact bacteria can be detected in situ, i.e. in their natural environment. As a result, the bacteria can not only be quantified, but also possible associations between different bacterial groups can be demonstrated.
- the permeabilization can very particularly preferably take place by partial degradation by means of cell wall lytic enzymes, preferably selected from a group consisting of lysozyme, lysostaphin, proteinase K, pronase and mutanolysin.
- cell wall lytic enzymes preferably selected from a group consisting of lysozyme, lysostaphin, proteinase K, pronase and mutanolysin.
- an oligonucleotide suitable as a positive control is also provided.
- Such an oligonucleotide is characterized in that it detects as many, optimally all, of the bacteria or eurkaryotes contained in the analyzed sample.
- the oligonucleotide EUB338 (bacteria) or the oligonucleotide EUK (eukaryotes) described by Amann et al. (1990) is suitable.
- Such a positive control can be used to check that the procedure used has been carried out correctly. Above all, however, it allows the determination of a percentage of the specifically detected microorganisms compared to the
- kits for the detection and / or quantification of microorganisms on the skin are advantageous.
- the use of the kit, in particular in the method according to the invention, in the search for active substances, in the analysis of the microflora of the skin and in testing the effect of cosmetics containing active substances is advantageous.
- the investigation of both human and animal skin directly or in samples taken from them can be carried out efficiently with the kits according to the invention and also against a high background of other microorganisms.
- the plastic cylinder which is open on both sides, is pressed with the undamaged side onto the skin surface to be examined and with 1.5 ml of the detergent solution (a physiological Tween buffer solution, pH 8.0 with 0.523 KH 2 PO 4 g / liter, 16.73 K 2 HP0 4 g / liter, 8.50 NaCI g / liter, 10.00 tween 80 g / liter and 1.00 trypton g / liter).
- the detergent solution a physiological Tween buffer solution, pH 8.0 with 0.523 KH 2 PO 4 g / liter, 16.73 K 2 HP0 4 g / liter, 8.50 NaCI g / liter, 10.00 tween 80 g / liter and 1.00 trypton g / liter.
- the two liquids are combined. Part of the sample from the two combined liquids is used for the subsequent detection using oligonucleotides, another part is used for the control, which is carried out in parallel, by culturing the microorganisms contained in the sample.
- Sterile water e.g. Millipore water
- Millipore water Sterile water
- a volume of absolute ethanol is then added to the sample taken and centrifuged (room temperature, 8,000 rpm, 5 minutes). The supernatant is discarded and the pellet washed in a volume of 1 x PBS solution. Finally, the pellet is resuspended in 1/10 volume of fixative (50% ethanol) and stored at -20 ° C until further use. An aliquot of the cell suspension is applied to a slide and dried (46 ° C, 30 min or until completely dry). The cells are then completely dehydrated by applying a further fixing solution (absolute ethanol) and dried again (46 ° C., 3 min or until completely dry).
- a suitable volume of a suitable enzyme solution is then applied and the sample incubated (room temperature, 15 min). This step may be repeated with another suitable enzyme solution.
- the permeabilization solution is removed with distilled water and the sample is completely dried again (incubation at 46 ° C. to completely dry).
- the cells are then completely dehydrated again by applying the fixing solution (absolute ethanol) and dried again (46 ° C., 3 min or until completely dry).
- hybridization solution with the oligonucleotides specific for the microorganisms to be detected in each case is then applied to the fixed, fully digested and dehydrated cells.
- the slide is then placed in a chamber moistened with hybridization solution (without oligonucleotides) (46 ° C, 90 min).
- the slide is then immersed in a chamber filled with washing solution and incubated (46 ° C., 15 min).
- the slide is then briefly immersed in a chamber filled with distilled water and then air-dried in the lateral position (46 ° C, 30 min or until completely dry). detection:
- the slide is then embedded in a suitable embedding medium. Finally, the sample is analyzed using a fluorescence microscope.
- Microorganism samples were taken from the forehead of a female test subject with combination skin (typified by a beautician and confirmed by sebometer measurements) using the sampling method described above.
- propionibacteria A very high proportion of propionibacteria was found by counting the fluorescence signals and comparing them with the total number of cells (> 90%). A small proportion of staphylococci was found ( ⁇ 10%). No corynebacteria were found.
- a microorganism sample was taken from the skin of another female subject using the sampling method described above.
- the 16 S rRNA gene of a microorganism was isolated from part of the sample. The subsequent sequence determination showed that it is a new sequence, but the microorganism can be assigned to the genus Corynebacterium. This sequence, on the basis of which a corresponding probe (according to SEQ ID No. 21) was developed, which can detect this microorganism, is under SEQ ID No. 31 specified in the sequence listing.
- Another part of the sample was hybridized with the previously described bacteria-specific probe EUB and with a probe mixture (SEQ ID No. 07 to 11) for the detection of the skin-relevant Corynebacteria.
- a high proportion of corynebacteria was determined by counting the fluorescence signals and comparing them with the total number of cells that had been recorded by the bacteria-specific probe (approx. 73%).
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10232775 | 2002-07-18 | ||
| DE2002132775 DE10232775A1 (de) | 2002-07-18 | 2002-07-18 | Nachweis von Mikroorganismen |
| DE2003106616 DE10306616A1 (de) | 2003-02-14 | 2003-02-14 | Kit zum Nachweis von Mikroorganismen |
| DE10306616 | 2003-02-14 | ||
| PCT/EP2003/007718 WO2004009843A2 (de) | 2002-07-18 | 2003-07-16 | Nachweis von mikroorganismen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP1523580A2 true EP1523580A2 (de) | 2005-04-20 |
Family
ID=30771716
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP03765005A Withdrawn EP1523580A2 (de) | 2002-07-18 | 2003-07-16 | Nachweis von mikroorganismen |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20050202476A1 (enExample) |
| EP (1) | EP1523580A2 (enExample) |
| JP (1) | JP2005532818A (enExample) |
| AU (1) | AU2003257470A1 (enExample) |
| BR (1) | BR0312770A (enExample) |
| RU (1) | RU2005103818A (enExample) |
| WO (1) | WO2004009843A2 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1668765A (zh) * | 2002-07-18 | 2005-09-14 | 汉高两合股份公司 | 检测微生物的寡核苷酸 |
| CN100469391C (zh) * | 2004-06-10 | 2009-03-18 | 安米 | 人溶菌酶在制备治疗痤疮的药物中的应用 |
| JP4803477B2 (ja) * | 2004-12-06 | 2011-10-26 | 富士電機株式会社 | 微生物の計測方法 |
| JP5201818B2 (ja) * | 2006-11-10 | 2013-06-05 | キヤノン株式会社 | プローブセット、プローブ固定担体及び遺伝子検査方法 |
| DE102007021387A1 (de) | 2007-05-04 | 2008-11-06 | Eads Deutschland Gmbh | Detektionsvorrichtung zur Detektion von biologischen Mikropartikeln wie Bakterien, Viren, Sporen, Pollen oder biologische Toxine, sowie Detektionsverfahren |
| US20110044968A1 (en) * | 2008-03-10 | 2011-02-24 | Pharmal N Corporation | Compositions for treatment with metallopeptidases, methods of making and using the same |
| WO2013155370A1 (en) * | 2012-04-13 | 2013-10-17 | The Regents Of The University Of California | Sinusitis diagnostics and treatments |
| JP2015524653A (ja) * | 2012-07-13 | 2015-08-27 | ロレアル | 対象における薄皮状態のインビトロ診断方法及び関連用途 |
| FR3097560B1 (fr) * | 2019-06-24 | 2021-06-25 | Oreal | Méthode de diagnostic d’une exposition chronique à la pollution |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5541308A (en) * | 1986-11-24 | 1996-07-30 | Gen-Probe Incorporated | Nucleic acid probes for detection and/or quantitation of non-viral organisms |
| US6582908B2 (en) * | 1990-12-06 | 2003-06-24 | Affymetrix, Inc. | Oligonucleotides |
| US5474796A (en) * | 1991-09-04 | 1995-12-12 | Protogene Laboratories, Inc. | Method and apparatus for conducting an array of chemical reactions on a support surface |
| US5426025A (en) * | 1992-05-28 | 1995-06-20 | Florida State University | Species-specific DNA probes for vibrio vulnificus methods and kits |
| FR2733755B1 (fr) * | 1995-05-03 | 1997-07-11 | Bio Merieux | Fragment nucleotidique de l'arn ribosomique 16s de corynebacteries, sondes et amorces derivees, reactif et procede de detection |
| US6737248B2 (en) * | 1996-01-05 | 2004-05-18 | Human Genome Sciences, Inc. | Staphylococcus aureus polynucleotides and sequences |
| AU5595200A (en) * | 1999-06-04 | 2000-12-28 | Kairos Scientific Inc. | Multispectral taxonomic identification |
| CN1668765A (zh) * | 2002-07-18 | 2005-09-14 | 汉高两合股份公司 | 检测微生物的寡核苷酸 |
-
2003
- 2003-07-16 EP EP03765005A patent/EP1523580A2/de not_active Withdrawn
- 2003-07-16 AU AU2003257470A patent/AU2003257470A1/en not_active Abandoned
- 2003-07-16 JP JP2004522471A patent/JP2005532818A/ja not_active Withdrawn
- 2003-07-16 WO PCT/EP2003/007718 patent/WO2004009843A2/de not_active Ceased
- 2003-07-16 RU RU2005103818/13A patent/RU2005103818A/ru not_active Application Discontinuation
- 2003-07-16 BR BR0312770-2A patent/BR0312770A/pt not_active IP Right Cessation
-
2005
- 2005-01-18 US US11/038,367 patent/US20050202476A1/en not_active Abandoned
Non-Patent Citations (1)
| Title |
|---|
| See references of WO2004009843A2 * |
Also Published As
| Publication number | Publication date |
|---|---|
| RU2005103818A (ru) | 2005-11-10 |
| WO2004009843A2 (de) | 2004-01-29 |
| BR0312770A (pt) | 2005-05-03 |
| JP2005532818A (ja) | 2005-11-04 |
| AU2003257470A1 (en) | 2004-02-09 |
| WO2004009843A3 (de) | 2004-05-21 |
| US20050202476A1 (en) | 2005-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE102007041864B4 (de) | Verfahren zum Nachweis von Bakterien und Pilzen | |
| DE3486467T3 (de) | Verfahren zum Nachweis, Identifizieren und Quantifizieren von Organismen und Viren | |
| DE19732086C2 (de) | Verfahren zur quantitativen Bestimmung von Eubakterien | |
| DE69527154T2 (de) | Spezifische und universelle amplifizierungs-primer zur raschen bestimmung und identifizierung ueblicher bakterieller pathogene und antibiotikaresistenzgene in klinischen proben zur routinediagnose in mikrobiologie-laboratorien | |
| DE69032778T2 (de) | Verfahren zur Untersuchung von durch Mikroorganismen verursachten Lebensmittelvergiftungen und Reagens dafür | |
| EP1177319B1 (de) | Verfahren zum nachweisen von mikroorganismen in einer probe | |
| EP1523579A2 (de) | Obligonukleotide zum nachweis von mikroorganismen | |
| EP1523580A2 (de) | Nachweis von mikroorganismen | |
| DE10232775A1 (de) | Nachweis von Mikroorganismen | |
| DE10129410A1 (de) | Verfahren zum spezifischen Schnellnachweis bierschädlicher Bakterien | |
| DE19955303A1 (de) | Test von Mikroorganismen | |
| DE102012103730A1 (de) | Nachweisverfahren für Mycobacterium avium ssp. paratuberculosis | |
| EP1490507B1 (de) | Verfahren zum nachweis von mikroorganismen mittels in situ-hybridisierung und durchflusszytometrie | |
| DE10307732A1 (de) | Oligonukleotide zum Nachweis von Mikroorganismen | |
| DE10306616A1 (de) | Kit zum Nachweis von Mikroorganismen | |
| DE10232776A1 (de) | Oligonukleotide zum Nachweis von Mikroorganismen | |
| EP1335991B1 (de) | Verfahren zum nachweis von protozoen der gattung naegleria | |
| DE10106370B4 (de) | Oligonukleotidsonden zur Detektion von parodontopathogenen Bakterien mittels in situ-Hybridisierung | |
| WO2001007649A2 (de) | Verfahren zum nachweis von mikroorganismen | |
| DE19936875C2 (de) | Verfahren zum Nachweisen von Mikroorganismen in einer Probe | |
| DE69405005T2 (de) | Sonde und verfahren zum nachweis von hefen der art candida krusei | |
| EP1208237A2 (de) | Schneller, hochspezifischer nachweis von pseudomonas aeruginosa durch mehrfachsondendetektion | |
| WO2003066894A2 (de) | Gensonden zum nachweis von spezies der gattung oenococcus | |
| EP1280603A2 (de) | Verfahren zur identifizierung, quantifizierung und visualisierung von mikroorganismen | |
| EP1725675A1 (de) | Verfahren zur identifizierung von gegen geruchskeime antibakteriell wirksamen substanzen und von substanzen, die im axillaren bereich pr biotisch wirksam sind |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20041214 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
| RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: SAETTLER, ANDREA Inventor name: BERGMAIER, INGRID Inventor name: MUELLNER, STEFAN Inventor name: BEIMFOHR, CLAUDIA Inventor name: JASSOY, CLAUDIA Inventor name: LUDWIG, WOLFGANG Inventor name: NIEVELER, SILKE Inventor name: MAIENSCHEIN, VERA Inventor name: TREBESIUS, KARL-HEINZ Inventor name: BAMBERG, RICHARD, ROBERT Inventor name: SCHLEIFER, KARL-HEINZ Inventor name: SCHOLTYSSEK, REGINE Inventor name: WEISS, ALBRECHT |
|
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: HENKEL AG & CO. KGAA |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20100202 |